Kumiya Sugiyama Selected Research

Kumiya Sugiyama Research Topics

Disease

11	Asthma (Bronchial Asthma) 03/2023 - 05/2008
7	Bites and Stings (Sting) 01/2020 - 07/2012
7	Hypersensitivity (Allergy) 11/2019 - 12/2008
5	Inflammation (Inflammations) 09/2021 - 05/2002
3	COVID-19 03/2022 - 09/2021
3	Airway Remodeling 09/2021 - 01/2007
3	Anaphylaxis (Anaphylactic Shock) 01/2020 - 06/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2021 - 07/2021
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2017
2	Disseminated Intravascular Coagulation 01/2018 - 01/2017
1	Miliary Tuberculosis 03/2022
1	Emphysema 07/2021
1	Wheat Hypersensitivity (Wheat Allergy) 11/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Small Cell Carcinoma 01/2018
1	Immediate Hypersensitivity 01/2015
1	Polymyositis 08/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2013
1	Fibrosis (Cirrhosis) 05/2013
1	Allergic Rhinitis 05/2013
1	Churg-Strauss Syndrome (Allergic Angiitis) 10/2012
1	Chronic Hepatitis C 10/2012
1	Eosinophilia 10/2012
1	Respiratory Hypersensitivity 10/2012
1	Lung Injury 01/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012
1	Cough 12/2008
1	Neoplasms (Cancer) 01/2007
1	Abscess 01/2007
1	Back Pain (Backache) 01/2007
1	Sepsis (Septicemia) 01/2007
1	Osteomyelitis 01/2007
1	Bronchopulmonary Dysplasia 09/2003

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin E (IgE)IBA 07/2015 - 07/2012
5	VenomsIBA 07/2015 - 07/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 02/2010
4	CytokinesIBA 01/2017 - 05/2002
3	mRNA VaccinesIBA 03/2022 - 09/2021
3	BNT162 VaccineIBA 03/2022 - 09/2021
3	AllergensIBA 07/2015 - 01/2015
2	ElastinIBA 09/2021 - 07/2021
2	Peptides (Polypeptides)IBA 09/2021 - 09/2003
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 01/2018
2	Dacarbazine (DIC)FDA LinkGeneric 01/2018 - 01/2017
2	ThrombomodulinIBA 01/2018 - 01/2017
2	C-Reactive ProteinIBA 01/2018 - 01/2017
2	Interleukin-4 (Interleukin 4)IBA 01/2017 - 05/2013
2	Wasp Venoms (Venom, Wasp)IBA 07/2015 - 06/2013
2	AntigensIBA 08/2013 - 10/2012
2	LeukotrienesIBA 05/2013 - 05/2002
2	Interleukin-13IBA 05/2013 - 05/2008
1	VaccinesIBA 03/2022
1	SteroidsIBA 03/2022
1	AntibodiesIBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	HLA-DQ Antigens (HLA-DQ)IBA 11/2019
1	Soaps (Soap)IBA 11/2019
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2018
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2018
1	Fibrinogen (Factor I)FDA Link 01/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	Formoterol Fumarate (Oxis)FDA Link 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	AntithrombinsIBA 01/2018
1	antithrombin III-protease complexIBA 01/2018
1	Interleukin-33IBA 01/2017
1	Arthropod VenomsIBA 07/2015
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2015
1	Caffeine (No Doz)FDA LinkGeneric 01/2015
1	anti-IgE antibodiesIBA 06/2013
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2013
1	cysteinyl-leukotrieneIBA 05/2013
1	leukotriene-C4 synthaseIBA 05/2013
1	Leukotriene C4IBA 05/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2012
1	InterferonsIBA 10/2012
1	Interferon-alpha (Interferon Alfa)IBA 10/2012
1	Riluzole FDA LinkGeneric 01/2012
1	Bronchodilator Agents (Bronchodilators)IBA 12/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2007
1	Interleukin-10 (Interleukin 10)IBA 01/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2007
1	BombesinIBA 09/2003
1	ChemokinesIBA 05/2002

Therapy/Procedure

3	Therapeutics 06/2013 - 02/2010
1	Emergency Treatment 01/2020
1	Nebulizers and Vaporizers (Inhaler) 01/2018